Page last updated: 2024-10-24

chlorambucil and Obesity

chlorambucil has been researched along with Obesity in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RĂ¼th, EM1
Kemper, MJ1
Leumann, EP1
Laube, GF1
Neuhaus, TJ1

Other Studies

1 other study available for chlorambucil and Obesity

ArticleYear
Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome.
    The Journal of pediatrics, 2005, Volume: 147, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Alkylating; Child, Preschool; Chlorambucil; C

2005